Recent posts

TypeTitleAuthorRepliesLast updated
News Article Or Scientific ReferenceProstate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferencePPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceMilk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceA pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceIntravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceLack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceDutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) stud Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceA 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceAn open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceEffects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. Mikael Nordfors012 years 7 months ago
News Article Or Scientific ReferenceThe development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline Mikael Nordfors012 years 8 months ago
News Article Or Scientific ReferencePrediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer. Mikael Nordfors012 years 8 months ago
News Article Or Scientific Reference Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention Mikael Nordfors012 years 8 months ago
News Article Or Scientific ReferenceTreatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecula Mikael Nordfors012 years 8 months ago
News Article Or Scientific ReferenceBoswellic acids: biological actions and molecular targets. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceRole of everolimus in the treatment of renal cell carcinoma. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceDasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferencePhase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceAction of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceCirculating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceImproving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceFinal analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceA phase II clinical trial of sorafenib in androgen-independent prostate cancer. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferenceThe anti-angiogenic basis of metronomic chemotherapy. Mikael Nordfors012 years 9 months ago
News Article Or Scientific ReferencePsychodynamic psychotherapy, therapeutic touch and cancer. A review of the method of intervention and studv of 75 cases Mikael Nordfors012 years 9 months ago

Pages